This activation enhances glucose uptake via upregulated GLUT4 expression and GLUT1 membrane translocation to bypass insulin resistance, while simultaneously reprogramming lipid metabolism through ACC1/ACC2 inhibition to drive fatty acid β-oxidation (25–27), thereby prioritizing energy allocation to critical organs including the heart and brain. The gene discussed is SLC2A4; the disease is Insulin resistance.